Olivia C. Ware serves as Executive at Revance Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Olivia C. Ware has executed 12 insider transactions totaling $1.2M, demonstrating a bearish approach to their equity position. Their most recent transaction on May 1, 2024 involved receiving (via award) 15,000 shares valued at $0.
Olivia C. Ware currently holds 31,675 shares of Revance Therapeutics, Inc. (RVNC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Olivia C. Ware has been a net seller of RVNC stock. They have purchased $0 and sold $1.2M worth of shares.
Olivia C. Ware's most recent insider trade was on May 1, 2024, when they sold 15,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $55.36 |
| Planned |
| Apr 16, 2024 | ACLX | $146.4K | Sale | 2,612 | $56.03 | Planned |
| Apr 16, 2024 | ACLX | $71.5K | Option Exercise | 9,402 | $7.61 | Planned |
| Mar 15, 2024 | ACLX | $68.5K | Option Exercise | 9,000 | $7.61 | Planned |
| Mar 15, 2024 | ACLX | $131.9K | Sale | 1,900 | $69.44 | Planned |
| Mar 15, 2024 | ACLX | $264.8K | Sale | 3,763 | $70.36 | Planned |
| Mar 15, 2024 | ACLX | $236.9K | Sale | 3,337 | $70.99 | Planned |
| May 3, 2023 | RVNC | $0 | Award | 3,534 | $N/A | Discretionary |
| May 4, 2022 | RVNC | $0 | Award | 6,059 | $N/A | Discretionary |
| May 5, 2021 | RVNC | $0 | Award | 674 | $N/A | Discretionary |
| Mar 8, 2021 | RVNC | $0 | Award | 6,408 | $N/A | Discretionary |